Radiance Therapeutics | Finanzwire

Basculer en Français

10656	Companies
226798	Keywords
155228	Articles
120063	Press releases

Headlines Articles Press releases Radiance Therapeutics

Home
Companies
Radiance Therapeutics

BRIEF

published on 03/05/2024 at 15:05, 2 years 3 months ago

Radiance Therapeutics to Attend LSI USA '24 Emerging Medtech Summit in Dana Point, CA

Radiance Therapeutics Ophthalmic Devices FDA 510(k) Clearance Medtech Summit Emerging Medtech
PRESS RELEASE

published on 03/05/2024 at 15:00, 2 years 3 months ago

Radiance Therapeutics to Attend LSI USA '24 Emerging Medtech Summit in Dana Point, CA
Radiance Therapeutics, Inc. CEO Laurence Marsteller MD to represent the company at LSI USA '24 Emerging Medtech Summit. Event offers collaboration & investment opportunities in ophthalmic healthcare

Radiance Therapeutics Investment Opportunities LSI USA '24 Emerging Medtech Summit Ophthalmic Healthcare
PRESS RELEASE

published on 01/05/2024 at 13:50, 2 years 5 months ago

Radiance Therapeutics to Present at the Biotech Showcase 2024 in San Francisco
Radiance Therapeutics, an innovation leader in ophthalmic devices, is excited to announce the presentation by CEO Laurence Marsteller at Biotech Showcase™ 2024 in San Francisco, CA. The presentation will focus on the latest developments and how the company's innovation can address unmet needs in ophthalmic treatments. Interested parties are invited to register and attend the event to discover the potential of Radiance Therapeutics' technology.

Innovation Biotech Showcase 2024 Radiance Therapeutics Ophthalmic Devices Laurence Marsteller

Accesswire

Published on 06/29/2026 at 15:00, 1 hour 13 minutes ago

Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 1 hour 13 minutes ago

Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 1 hour 43 minutes ago

Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 1 hour 43 minutes ago

Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 14:30, 1 hour 43 minutes ago

US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher

View all ACCESSWIRE

EQS Group

Published on 06/29/2026 at 15:34, 39 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/29/2026 at 15:33, 40 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 06/29/2026 at 15:32, 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 06/29/2026 at 15:31, 42 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 06/29/2026 at 15:30, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited

Les Echos

Published on 06/29/2026 at 10:56, 5 hours 17 minutes ago

GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
Published on 06/26/2026 at 17:45, 2 days 22 hours ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 14:44, 3 days 1 hour ago

Safran information
Published on 06/26/2026 at 07:00, 3 days 9 hours ago

Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 17:50, 3 days 22 hours ago

DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE